{"data":{"id":"us/21-cfr-357.280","jurisdiction":"us","citation":"21 CFR 357.280","heading":"Professional labeling.","body":"The labeling provided to health professionals (but not to the general public) may contain the following information for ingredients identified in § 357.210: Indication. “For visualization of biliary ducts during cholecystography.”","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 357—MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE","Subpart C—Cholecystokinetic Drug Products"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"db1622fb58524ee60c63b4f842abae2706ee77823cf66b216d99227b1d075f68","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-357.250","next":"us/21-cfr-357.801"},"notice":"GroundRules: Original legal text. Not legal advice."}